Clinical StudiesAcid suppression by famotidine 20 mg twice daily or 40 mg twice daily in preventing relapse of endoscopic recurrence of erosive esophagitis
References (17)
- et al.
Healing and relapse of severe peptic esophagitis after treatment with omeprazole
Gastroenterology
(1988) - et al.
Dose-response effect of famotidine on patterns of gastro-oesophageal reflux
Aliment Pharmacol Ther
(1988) - et al.
Randomized, placebo-controlled comparison of famotidine 20 mg b.d. or 40 mg b.d. in patients with erosive esophagitis
Aliment Pharmacol Ther
(1994) - et al.
Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameter
Dig Dis Sci
(1988) Rolling review: Gastrooesophageal reflux disease
Aliment Pharmacol Ther
(1993)- et al.
Three year follow up of patients with gastroesophageal reflux disease
Gut
(1992) - et al.
Long-term strategy for the treatment of gastro-oesophageal reflux disease
Gastroenterol Int
(1991) Epidemiology and natural history of gastro-oesophageal reflux disease
Digestion
(1992)
There are more references available in the full text version of this article.
Cited by (12)
Gastroesophageal reflux
2005, European Journal of Internal MedicineOverview of medical therapy for gastroesophageal reflux disease
1999, Gastroenterology Clinics of North AmericaMaintenance therapy of gastroesophageal reflux disease
2010, Clinical Journal of GastroenterologyAn evidence-based, Latin-American consensus on gastro-oesophageal reflux disease
2006, European Journal of Gastroenterology and Hepatology
Copyright © 1995 Published by Elsevier Inc.